Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 13, Number 3, 1998

Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)
pp. 159-182(24)
Authors: Fulmer Shealy, Y; Frye, JL; Hill, DL; Sani, BP; Rogers, TS; Riordan, JM; Krauth, CA; Lin, T-H; Eto, I; Grubbs, CJ

Favourites:
ADD
Favourites:
ADD

Sequence-specific DNA alkylation of novel tallimustine derivatives
pp. 193-205(13)
Authors: Marchini, S; Cozzi, P; Beria, I; Capolongo, L; D'Incalci, M; Broggini, M

Favourites:
ADD

Assessment of toxicity of bis-platinum complexes in hypoxic and aerobic cells
pp. 207-220(14)
Authors: Skov, KA; Adomat, H; Farrell, NP; Matthews, JB

Favourites:
ADD
Favourites:
ADD

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more